Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hyperglycemia - Overview
Hyperglycemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperglycemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hyperglycemia - Companies Involved in Therapeutics Development
Auxulin Pharmaceuticals Inc
Boryung Pharmaceutical Co Ltd
FGH BioTech Inc
Guangzhou General Pharmaceutical Research Institute Co Ltd
Hyperglycemia - Drug Profiles
AUX-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs to Inhibit ABHD6 for Metabolic Disorders - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FGH-10019 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KR-62980 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonise PPARG and Antagonize AGTR1 for Hyperglycemia and Hypertension - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit SGLT2 for Hyperglycemia and Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize PST Receptor for Dysglycemic States - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit PEPCK for Hyperglycemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Antagonize Glucagon Receptor for Hyperglycemia and Type 2 Diabetes - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hyperglycemia - Dormant Projects
Hyperglycemia - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Hyperglycemia, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Hyperglycemia, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Hyperglycemia - Pipeline by Auxulin Pharmaceuticals Inc, H1 2020
Hyperglycemia - Pipeline by Boryung Pharmaceutical Co Ltd, H1 2020
Hyperglycemia - Pipeline by FGH BioTech Inc, H1 2020
Hyperglycemia - Pipeline by Guangzhou General Pharmaceutical Research Institute Co Ltd, H1 2020
Hyperglycemia - Dormant Projects, H1 2020
Hyperglycemia - Discontinued Products, H1 2020